Market Cap (In USD)
321.91 Thousand
Revenue (In USD)
-
Net Income (In USD)
-4.76 Million
Avg. Volume
66.02 Thousand
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.0011-0.054
- PE
- -
- EPS
- -
- Beta Value
- 1.823
- ISIN
- US67001N1072
- CUSIP
- 67001N107
- CIK
- 1039466
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Dr. Dwain K. Morris-Irvin M.P.H., MPH, Ph.D.
- Employee Count
- -
- Website
- https://novaccessglobal.com
- Ipo Date
- 1998-09-21
- Details
- NovAccess Global Inc., a biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States. The company specializes in cutting-edge research related to utilizing a patient's immune system to attack the cancer. NovAccess Global Inc. was incorporated in 1997 and is headquartered in Chesterland, Ohio.
More Stocks
-
BSEAFBraemar Plc
BSEAF
-
KPLUYK+S Aktiengesellschaft
KPLUY
-
RKVA
-
GARWF
-
CEN
-
SRINDS.R. Industries Limited
SRIND
-
9401TBS Holdings,Inc.
9401
-
DATSWDatChat, Inc.
DATSW